RxDoctor Payments Data

Larry Presant, MD

Internal Medicine · Poway, CANPI 1790751956

Payments from drug & device makers

$2,377in general payments, 2019–2025

Across 118 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$503
  • AstraZeneca$221
  • Amgen$209
  • Lilly USA, LLC$201
  • Novo Nordisk$153
  • Pfizer$136
  • plus $954 from 23 others

What the payments were for

  • Food & beverage$2,34599%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,377 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$87,977
Medicare patients
182
Services billed
881

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$66,559
OzempicSemaglutide31$52,410
JardianceEmpagliflozin18$17,125
JanuviaSitagliptin Phosphate11$6,343
Atorvastatin Calcium397$3,436
Nebivolol Hcl21$2,180
Tamsulosin Hcl148$2,140
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide101$2,091
Amlodipine Besylate254$1,905
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$1,842
Lisinopril194$1,690
Levothyroxine Sodium154$1,570
Estradiol22$1,532
Fluticasone Propionate65$1,402
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen29$1,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$136$66,55947 claims
Novo NordiskOzempic$153$52,41031 claims
Boehringer IngelheimJardiance$41$17,12518 claims
MerckJanuvia$74$6,34311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 13,581 internal medicine providers in California.

Other internal medicine in Poway

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →